Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Nuclear beta-catenin accumulation as a prognostic factor in Dukes' D human colorectal cancers.

Miyamoto S, Endoh Y, Hasebe T, Ishii G, Kodama K, Goya M, Ono M, Saitoh N, Chiba T, Ochiai A.

Oncol Rep. 2004 Aug;12(2):245-51.

PMID:
15254684
2.

MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis.

Baldus SE, Mönig SP, Huxel S, Landsberg S, Hanisch FG, Engelmann K, Schneider PM, Thiele J, Hölscher AH, Dienes HP.

Clin Cancer Res. 2004 Apr 15;10(8):2790-6.

3.

Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer.

Wong SC, Lo ES, Lee KC, Chan JK, Hsiao WL.

Clin Cancer Res. 2004 Feb 15;10(4):1401-8.

4.

Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.

Chung GG, Provost E, Kielhorn EP, Charette LA, Smith BL, Rimm DL.

Clin Cancer Res. 2001 Dec;7(12):4013-20.

5.

Clinical significance of E-cadherin-catenin complex expression in metastatic foci of colorectal carcinoma.

Ikeguchi M, Makino M, Kaibara N.

J Surg Oncol. 2001 Jul;77(3):201-7.

PMID:
11455558
6.

Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer.

Kawada M, Seno H, Uenoyama Y, Sawabu T, Kanda N, Fukui H, Shimahara Y, Chiba T.

Cancer Res. 2006 Mar 15;66(6):2913-7.

7.

Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.

Inagawa S, Itabashi M, Adachi S, Kawamoto T, Hori M, Shimazaki J, Yoshimi F, Fukao K.

Clin Cancer Res. 2002 Feb;8(2):450-6.

8.

Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.

Pancione M, Forte N, Sabatino L, Tomaselli E, Parente D, Febbraro A, Colantuoni V.

Hum Pathol. 2009 May;40(5):714-25. doi: 10.1016/j.humpath.2008.08.019. Epub 2009 Jan 3.

PMID:
19121846
9.

Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.

Maelandsmo GM, Holm R, Nesland JM, Fodstad Ø, Flørenes VA.

Clin Cancer Res. 2003 Aug 15;9(9):3383-8.

10.
11.

Intracellular distribution of beta-catenin in colorectal adenomas, carcinomas and Peutz-Jeghers polyps.

Herter P, Kuhnen C, Müller KM, Wittinghofer A, Müller O.

J Cancer Res Clin Oncol. 1999;125(5):297-304.

PMID:
10359135
12.

Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer.

Ougolkov AV, Yamashita K, Mai M, Minamoto T.

Gastroenterology. 2002 Jan;122(1):60-71.

PMID:
11781281
13.

[Expressions of beta-catenin, p53 and proliferating cell nuclear antigen in the carcinogenesis of colorectal adenoma].

Wu W, Zhang X, Yan X, Wang J, Zhang J, Li Y.

Zhonghua Zhong Liu Za Zhi. 2002 May;24(3):264-7. Chinese.

PMID:
12515622
14.

Cadherin-catenin expression in primary colorectal cancer: a survival analysis.

Hugh TJ, Dillon SA, Taylor BA, Pignatelli M, Poston GJ, Kinsella AR.

Br J Cancer. 1999 Jun;80(7):1046-51.

15.

Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.

Chen S, Liu J, Li G, Mo F, Xu X, Zhang T, Zhang X, Li J, Han X, Sun Y.

Scand J Gastroenterol. 2008;43(4):456-64. doi: 10.1080/00365520701785194.

PMID:
18365911
16.

Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer.

Pancione M, Forte N, Fucci A, Sabatino L, Febbraro A, Di Blasi A, Daniele B, Parente D, Colantuoni V.

Hum Pathol. 2010 Jun;41(6):867-76. doi: 10.1016/j.humpath.2009.09.019. Epub 2010 Feb 4.

PMID:
20129645
17.

Possible contribution of CD44 variant 6 and nuclear beta-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma.

Masaki T, Goto A, Sugiyama M, Matsuoka H, Abe N, Sakamoto A, Atomi Y.

Cancer. 2001 Nov 15;92(10):2539-46.

PMID:
11745187
18.

Loss of beta-catenin expression in metastatic gastric cancer.

Ebert MP, Yu J, Hoffmann J, Rocco A, Röcken C, Kahmann S, Müller O, Korc M, Sung JJ, Malfertheiner P.

J Clin Oncol. 2003 May 1;21(9):1708-14.

PMID:
12721245
19.

[The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma].

Duan GJ, Yan XC, Bian XW, Li J, Chen X.

Zhonghua Bing Li Xue Za Zhi. 2004 Dec;33(6):518-22. Chinese.

PMID:
15634446
20.

Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma.

Hori H, Fujimori T, Fujii S, Ichikawa K, Ohkura Y, Tomita S, Ono Y, Imura J, Kuroda Y.

Dis Colon Rectum. 2005 May;48(5):938-45.

PMID:
15785891
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk